Affinage

VCP

Transitional endoplasmic reticulum ATPase · UniProt P55072

Length
806 aa
Mass
89.3 kDa
Annotated
2026-06-11
100 papers in source corpus 41 papers cited in narrative 38 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 8/8 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

VCP/p97 (yeast Cdc48) is a hexameric AAA+ ATPase segregase that uses ATP hydrolysis to extract and unfold ubiquitinated client proteins from membranes, chromatin, and protein complexes, delivering them to the proteasome or autophagy machinery (PMID:34951965, PMID:38401542). With its core cofactor Ufd1-Npl4, VCP cooperatively engages polyubiquitin chains rather than the substrate directly, unfolds an initiator ubiquitin, and threads the linked chain and substrate segments through its central pore (PMID:34951965); SUMO-polyubiquitin hybrid chains accelerate this unfolding through Ufd1-SUMO contacts (PMID:36574706). Substrate handoff to the 26S proteasome is bidirectional and depends on adaptor cofactors (Rad23, Ubx5/Shp1) that partition polyubiquitin binding and stimulate unfolding (PMID:38401542), and direct Cdc48-20S coaxial coupling occurs through the D2-ring pore-2 loop (PMID:26134898, PMID:24711419). VCP performs ubiquitin-dependent chromatin extraction across diverse contexts: removing Aurora B during mitotic exit (PMID:21486945, PMID:20130676), cycling condensin during chromosome condensation (PMID:29452641), degrading stalled/damaged RNA polymerases (PMID:21211725, PMID:30192228), and extracting SUMO-ubiquitin-marked factors at replication forks and DNA-protein crosslinks (FAF1, Ubx5/Wss1) (PMID:34644576, PMID:37144685). VCP is also central to protein quality control: it drives ERAD retrotranslocation (PMID:16321991, PMID:19359248), stress-granule disassembly upon ULK1/2 phosphorylation (PMID:23791177, PMID:30979586), lysosomal clearance and TFEB-regulated lysosomal biogenesis (PMID:30654731), mitochondrial quality control via Mitofusin/MFN2 removal and PINK1-PRKN mitophagy (PMID:28322724, PMID:35389758, PMID:33966597), and Hsp70-assisted disaggregation of ubiquitylated tau fibrils (PMID:33004675, PMID:36732333). VCP additionally regulates autophagy initiation by stabilizing Beclin-1 through ATXN3 deubiquitinase activity and promoting PI3K complex I assembly (PMID:33510452, PMID:33719912). Its activity is tuned by post-translational modifications including UFMylation at K109 by UFL1 (PMID:38762759), phosphorylation at Thr76 (Plk1/PTEN), Ser784 (DUSP1), and Tyr805 (PTP4A2, gating UBXD1/PLAA-dependent lysophagy) (PMID:35430615, PMID:37464072, PMID:36300783), and acetylation (PMID:19335618). Disease-causing IBMPFD/MSP and dementia mutations (R155H, A232E, R155C, D395G) impair ERAD, autophagosome maturation, and tau disaggregation, establishing VCP as causal in multisystem proteinopathy and tauopathy (PMID:20008565, PMID:20104022, PMID:16321991, PMID:33004675, PMID:34289347).

Mechanistic history

Synthesis pass · year-by-year structured walk · 38 steps
  1. 1993 Medium

    Established VCP's first physical association in membrane traffic, showing it stoichiometrically binds clathrin and Hsc70 and might modulate protein-protein interactions in transport.

    Evidence Biochemical co-purification and co-immunoprecipitation from mammalian cell lysates

    PMID:8413590

    Open questions at the time
    • No functional mechanism assayed
    • Role of ATPase activity in clathrin/Hsc70 complex not tested
  2. 2005 High

    Linked IBMPFD disease mutations to a loss of ERAD function, showing R155H impairs degradation of an ERAD substrate despite normal ATPase activity and hexamer structure.

    Evidence Cell-based ERAD substrate degradation assays, ATPase measurement, native gel, immunofluorescence

    PMID:16321991

    Open questions at the time
    • Molecular basis of substrate-handling defect with intact ATPase unresolved
    • Did not establish whether mutation is gain or loss of function
  3. 2009 High

    Defined VCP as required for autophagosome maturation, distinguishing ubiquitin-dependent autophagy of substrates from starvation-induced autophagy and tying disease mutants to the defect.

    Evidence RNAi, dominant-negative overexpression, mCherry-EGFP-LC3 reporter, patient myoblasts

    PMID:20008565 PMID:20104022

    Open questions at the time
    • Did not resolve which maturation step VCP acts on
    • Cofactor requirements not defined
  4. 2009 Medium

    Mapped VCP as heavily phosphorylated/acetylated and identified a D2alpha/VAR regulatory region controlling ATPase activity.

    Evidence Mass spectrometry of modification sites plus site-directed mutagenesis with ATPase assays

    PMID:19335618

    Open questions at the time
    • Physiological enzymes and consequences of most modifications not established
    • Limited follow-up on regulatory outcomes
  5. 2011 High

    Extended VCP function to chromatin, showing it acts at sites of stalled transcription to facilitate processive proteasomal degradation of ubiquitinated Rpb1 after UV.

    Evidence Proteasome isolation/MS, chromatin fractionation, yeast genetics

    PMID:21211725

    Open questions at the time
    • Precise extraction step at chromatin not visualized
    • Generalization beyond Pol II unclear at the time
  6. 2010 High

    Connected VCP to chromosome bi-orientation via Cdc48-Shp1-driven nuclear localization of PP1, counteracting Aurora B at kinetochores.

    Evidence Yeast ts mutants, co-IP, localization imaging, genetic epistasis with ipl1

    PMID:20483956

    Open questions at the time
    • Direct substrate of Cdc48 in this pathway not identified
    • Conservation to human kinetochores not tested here
  7. 2011 High

    Demonstrated direct Cdc48-Ufd1-Npl4 removal of Aurora B from chromatin during mitotic exit across Xenopus and human systems, defining a mitotic role for the segregase.

    Evidence siRNA, quantitative IF, Aurora B kinase activity assay, epistasis with hesperadin

    PMID:20130676 PMID:21486945

    Open questions at the time
    • Whether Aurora B is a direct VCP substrate not shown biochemically
    • Ubiquitin ligase upstream unidentified
  8. 2011 Medium

    Showed the UBX cofactor Ubx4 modulates Cdc48-Ufd1-Npl4 for ERAD, defining distinct cofactor-dependent steps in substrate handling.

    Evidence Yeast genetics, ERAD substrate assays, co-IP, polyubiquitin accumulation

    PMID:19359248

    Open questions at the time
    • Mechanistic step controlled by Ubx4 vs Ubx2 not fully defined
    • Mammalian relevance untested
  9. 2012 Medium

    Identified a Vms1-dependent, Ufd1/Ufd2-independent Cdc48 route degrading the telomere regulator Cdc13 via both autophagy and proteasome.

    Evidence Yeast deletion mutants, Cdc13 stability assays, pathway inhibition genetics

    PMID:22718752

    Open questions at the time
    • Direct extraction mechanism not shown
    • Choice between autophagy and proteasome unexplained
  10. 2013 High

    Established granulophagy, a CDC48/VCP-dependent autophagic clearance of stress granules conserved from yeast to mammals and sensitive to disease mutations.

    Evidence Unbiased yeast genetic screen, fluorescence microscopy, RNAi, patient mutation expression

    PMID:23791177

    Open questions at the time
    • Substrate within stress granules targeted by VCP unidentified
    • Trigger for VCP recruitment unclear
  11. 2013 Medium

    Characterized a comprehensive IBMPFD mutant panel, showing all cause ERAD substrate accumulation and most enhance Ufd1-Npl4/p47 binding, with P137L as a distinct cofactor-binding-deficient outlier.

    Evidence ERAD assays, in vitro binding, co-IP, fractionation, IF

    PMID:23333620

    Open questions at the time
    • How enhanced cofactor binding causes dysfunction not resolved
    • Functional uniqueness of P137L mechanistically unexplained
  12. 2014 High

    Provided structural proof that Cdc48 and the 20S proteasome form a stable coaxial complex, showing coplanar N-D1 packing is sufficient for function.

    Evidence Site-specific cross-linking, single-particle EM, in vitro proteolysis (archaeal)

    PMID:24711419

    Open questions at the time
    • Relevance of archaeal coupling to eukaryotic 26S not established
    • Substrate handoff geometry not resolved
  13. 2015 Medium

    Pinpointed the D2-ring pore-2 loop as the element mediating Cdc48-20S interaction, separating proteasome communication from unfolding/ATPase activity, and linked an ALS mutation to this surface.

    Evidence In vitro binding of purified Cdc48 variants and 20S, ATPase, unfolding, hexamer stability assays

    PMID:26134898

    Open questions at the time
    • In-cell consequence of impaired 20S coupling not measured
    • Disease mechanism in neurons not tested
  14. 2016 Medium

    Revealed a neuronal role for VCP-p47-ATL1 in tubular ER formation and protein synthesis controlling dendritic spine density, with rescue by leucine.

    Evidence Knockdown, disease-mutation knockin mice, ER live imaging, protein synthesis and spine morphometry

    PMID:26984393

    Open questions at the time
    • Direct VCP substrate linking ER shape to translation unknown
    • Single lab
  15. 2017 Medium

    Identified Mitofusin as a target negatively regulated by VCP, with IBMPFD mutants as hyperactive alleles suppressible by VCP inhibitors in patient and fly models.

    Evidence Drosophila IBMPFD muscle model, patient fibroblasts, VCP inhibitors, mitochondrial morphology/respiration

    PMID:28322724

    Open questions at the time
    • Direct extraction of Mitofusin not biochemically reconstituted
    • Cofactor dependence unclear
  16. 2018 Medium

    Defined a sequential SUMO-ubiquitin-Cdc48 pathway degrading defective RNA Pol III, broadening VCP's transcriptional quality-control role.

    Evidence Yeast genetics, sumoylation/ubiquitylation assays, Cdc48 mutant and degradation analysis

    PMID:30192228

    Open questions at the time
    • Ligases and recognition determinants partially defined
    • Mammalian conservation untested
  17. 2018 Medium

    Showed Cdc48 acts as the segregase releasing self-entrapped condensin from chromatin to enable chromosome condensation.

    Evidence Yeast genetics, chromatin binding assays, ubiquitin mutant epistasis

    PMID:29452641

    Open questions at the time
    • Direct condensin ubiquitination/extraction not biochemically reconstituted
    • Single lab
  18. 2019 High

    Demonstrated ULK1/2 phosphorylate VCP to boost its ATPase activity and stress-granule disassembly, linking the kinases to VCP-disease-like myopathy with TDP-43 inclusions.

    Evidence Kinase assays, SG disassembly assays, VCP ATPase measurement, mouse knockouts, ULK agonists

    PMID:30979586

    Open questions at the time
    • Phosphosite(s) and structural mechanism of activation not mapped here
    • Substrate extracted from SGs unidentified
  19. 2019 High

    Established VCP as a central mediator of lysosomal clearance and TFEB-regulated lysosomal biogenesis in adult muscle, causing a necrotic myopathy distinct from ATG5 loss.

    Evidence Conditional muscle knockout mice, lysosomal damage markers, TFEB localization, ATG5-KO comparison

    PMID:30654731

    Open questions at the time
    • Molecular substrate at damaged lysosomes not defined here
    • Link to TFEB regulation mechanistically open
  20. 2020 High

    Identified VCP as a tau disaggregase whose activity is impaired by a dementia-associated D395G mutation, directly linking VCP to neurofibrillary tangle pathology.

    Evidence In vitro tau disaggregation with purified VCP, D395G knock-in mice with intracerebral tau injection

    PMID:33004675

    Open questions at the time
    • Cofactor requirements for in vivo disaggregation not defined here
    • Fate of disaggregated tau unresolved
  21. 2021 High

    Resolved the core unfolding mechanism: Cdc48-Ufd1/Npl4 recognizes the polyubiquitin chain, unfolds an initiator ubiquitin, and threads chain plus substrate through the pore to release unfolded client.

    Evidence In vitro reconstitution with purified yeast components, HDX-MS, translocation assays, mutagenesis

    PMID:34951965

    Open questions at the time
    • Cofactor-specific modulation of this cycle not fully mapped
    • Membrane-embedded substrate extraction not addressed
  22. 2021 High

    Defined a dual mechanism for VCP in autophagy initiation: stabilizing Beclin-1 via ATXN3 deubiquitination and promoting PI3K complex I assembly and PI(3)P production.

    Evidence VCP ATPase inhibitors, PI(3)P assays, co-IP, DUB activity, WIPI2/ATG16L/LC3 recruitment

    PMID:33510452 PMID:33719912

    Open questions at the time
    • Whether VCP directly extracts a ubiquitin from Beclin-1 unresolved
    • Structural basis of PI3K-complex assembly role unknown
  23. 2021 Medium

    Defined VCP(FAF1) chromatin extraction of SUMO/ubiquitin-modified proteins at blocked replication forks, cooperating with USP7 in a synthetic-lethal relationship.

    Evidence Co-IP, chromatin fractionation, C. elegans and mammalian genetics, synthetic lethality, inhibitor synergy

    PMID:34644576

    Open questions at the time
    • Identity of extracted fork-associated substrates partial
    • Single main lab
  24. 2021 Medium

    Established UBXN1/SAKS1 as the cofactor coupling VCP to PRKN-dependent mitophagy, facilitating MFN2 removal from the OMM.

    Evidence Co-IP, siRNA, mitophagy flux, IF translocation, domain mapping

    PMID:33966597

    Open questions at the time
    • Direct extraction of MFN2 by VCP not reconstituted
    • Single lab
  25. 2021 Medium

    Showed neuronal VCP loss recapitulates FTLD-TDP pathology and that disease mutant R155C behaves as a hypomorphic loss-of-function allele.

    Evidence Conditional neuronal knockout mice, R155C knock-in in null background, omics, TDP-43 IHC

    PMID:34289347

    Open questions at the time
    • Whether all MSP mutations are loss-of-function not generalized
    • Molecular driver of TDP-43 inclusions unclear
  26. 2022 High

    Showed SUMO modification of substrates accelerates VCP-mediated unfolding via Ufd1-SUMO contacts, with cryo-EM capturing the hybrid-chain engaged complex.

    Evidence In vitro unfolding with purified yeast proteins, single-particle cryo-EM

    PMID:36574706

    Open questions at the time
    • Generality of SUMO acceleration across substrates unclear
    • Physiological SUMO-Ub hybrid substrates in cells not enumerated
  27. 2022 High

    Defined Plk1 phosphorylation of VCP at Thr76 (reversed by PTEN) as a switch positioning VCP at the centrosome versus spindle, with cryo-EM showing nucleotide-pocket conformational changes.

    Evidence Kinase assay, phospho-mutant cell biology, siRNA, cryo-EM, co-localization, xenograft

    PMID:35430615

    Open questions at the time
    • Substrates extracted at centrosome/spindle not identified
    • Single lab
  28. 2022 Medium

    Established WIPI2 as the factor recruiting VCP to damaged mitochondria during PINK1-PRKN mitophagy for OMM protein degradation.

    Evidence Co-IP, RNAi, mitophagy flux, OMM degradation, cell death assays

    PMID:35389758

    Open questions at the time
    • Mechanism of WIPI2-VCP coupling structurally undefined
    • Single lab
  29. 2022 High

    Showed PTP4A2 dephosphorylation of VCP at Tyr805 enables binding of C-terminal cofactors UBXD1/PLAA (ELDR complex) for lysophagy, with in vivo relevance to kidney injury recovery.

    Evidence Substrate trapping/MS, dephosphorylation assays, co-IP, lysophagy assays, Ptp4a2-KO mice

    PMID:36300783

    Open questions at the time
    • Kinase that phosphorylates Tyr805 unidentified
    • Direct lysophagy substrate of VCP not defined
  30. 2023 High

    Showed VCP disaggregates ubiquitylated tau fibrils in neurons in cooperation with Hsp70 and the ubiquitin-proteasome system, but generates seeding-active byproducts.

    Evidence Cell/neuron clearance assays, VCP inhibitors, depletion, live imaging, seeding assays

    PMID:36732333

    Open questions at the time
    • Determinants partitioning clearance versus seed generation unclear
    • In vivo relevance of seeding byproducts untested
  31. 2023 Medium

    Identified DUSP1-mediated dephosphorylation of VCP at Ser784 as preserving mitochondrial quality control during endotoxemia in cardiomyocytes.

    Evidence Co-IP, phospho-antibodies, phosphomimetic mutagenesis, DUSP1 transgenic mice, HL-1 cells, mitochondrial assays

    PMID:37464072

    Open questions at the time
    • Kinase phosphorylating Ser784 not identified
    • Structural effect of Ser784 modification unknown
  32. 2023 Medium

    Showed nuclear VCP degrades HDAC1 to drive transcription of fatty-acid-oxidation genes (CPT1A) in colorectal cancer, defining a transcriptional/metabolic role.

    Evidence Co-IP, VCP inhibitor/knockdown, transcription assays, HDAC1 stability, cancer functional assays

    PMID:37788309

    Open questions at the time
    • Ubiquitin-dependence of HDAC1 extraction not fully defined
    • Cofactor involvement unknown
  33. 2023 Medium

    Defined VCP-UFD1-NPLOC4 as required for arsenic-induced degradation of PML/PML-RARA at PML bodies, recognizing SUMO/ubiquitin-modified PML.

    Evidence PML-body proteomics, p97 inhibition, siRNA, IF, PML modification analysis

    PMID:36880596

    Open questions at the time
    • Direct extraction kinetics not measured
    • Single lab
  34. 2023 Medium

    Showed Ubx5-Cdc48 assists Wss1 protease in clearing DNA-protein crosslinks and degrading RNA Pol II at lesions, defining a genotoxin-induced DPC repair role.

    Evidence Yeast genetics, inducible crosslink system, ChIP, epistasis, RNAPII degradation

    PMID:37144685

    Open questions at the time
    • Mammalian conservation untested
    • Order of Cdc48 versus Wss1 action partial
  35. 2024 High

    Resolved bidirectional substrate shuttling between the 26S proteasome and Cdc48-UN, defining cofactor roles (Rad23, Ubx5, Shp1) in partitioning polyubiquitin binding and stimulating unfolding.

    Evidence Minimal in vitro reconstitution with purified yeast components, degradation assays, yeast genetics

    PMID:38401542

    Open questions at the time
    • Regulatory logic determining handoff direction in cells unclear
    • Mammalian cofactor equivalents not tested
  36. 2024 Medium

    Identified UFMylation of VCP at K109 by UFL1 as a modification promoting BECN1 stabilization, PI3K complex assembly, and autophagy initiation, linking pathogenic mutations to reduced UFMylation.

    Evidence MS site ID, mutagenesis, co-IP, BECN1 stability and LC3B reporter assays

    PMID:38762759

    Open questions at the time
    • Structural consequence of K109 UFMylation unknown
    • How UFMylation affects ATPase cycle untested
  37. 2024 Medium

    Showed inhibited WRN helicase is extracted by p97/VCP for degradation in MSI-H cancer cells via a PIAS4-RNF4 SUMO-ubiquitin signal, extending segregase function to a synthetic-lethal vulnerability.

    Evidence Single-molecule tracking, WRN/p97 inhibition, PIAS4/RNF4 epistasis, chromatin fractionation

    PMID:39025847

    Open questions at the time
    • Cofactors mediating WRN extraction not defined
    • Single lab
  38. 2025 Medium

    Identified VCP and a defined set of its cofactors as controllers of tau seed amplification, with opposing inhibitor effects and cofactor-specific suppression/enhancement of seeding.

    Evidence Split-APEX2 proximity labeling, CRISPR/siRNA cofactor screen, tau seeding biosensors, inhibitor pharmacology

    PMID:39773263

    Open questions at the time
    • Mechanism distinguishing suppressor versus enhancer cofactors unresolved
    • Why two inhibitors act oppositely unexplained

Open questions

Synthesis pass · forward-looking unresolved questions
  • How VCP's full cofactor network and post-translational modification code combine to dictate substrate choice, the clearance-versus-seeding outcome of aggregate disaggregation, and the unified mechanism by which disease mutations span ERAD, autophagy, mitochondrial, and tau pathologies remains unresolved.
  • No single framework reconciles loss-of-function versus hyperactive disease-mutant behaviors
  • Substrate-selection logic across the cofactor repertoire not systematically defined
  • Structural basis for most regulatory PTMs unmapped

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140657 ATP-dependent activity 6 GO:0098772 molecular function regulator activity 4 GO:0140313 molecular sequestering activity 4 GO:0140096 catalytic activity, acting on a protein 3
Localization
GO:0005694 chromosome 6 GO:0005634 nucleus 4 GO:0005739 mitochondrion 4 GO:0005783 endoplasmic reticulum 3 GO:0005829 cytosol 2 GO:0005815 microtubule organizing center 1
Pathway
R-HSA-9612973 Autophagy 7 R-HSA-392499 Metabolism of proteins 5 R-HSA-1640170 Cell Cycle 4 R-HSA-1643685 Disease 4 R-HSA-73894 DNA Repair 3 R-HSA-74160 Gene expression (Transcription) 3
Complex memberships
Cdc48-20S proteasome coaxial complexCdc48-Ufd1-Npl4 (VCP-UFD1-NPLOC4) segregaseELDR lysophagy complex (VCP-UBXD1-PLAA)VCP-clathrin-Hsc70 complex

Evidence

Reading pass · 38 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2021 The Cdc48/p97 ATPase complex with its cofactor Ufd1/Npl4 (UN) recognizes polyubiquitin chains (rather than the substrate directly), cooperatively binds the chain, unfolds one ubiquitin molecule (initiator), then pulls all ubiquitins linked to its C terminus through the central pore of the hexameric double ring, causing transient ubiquitin unfolding; when the ATPase reaches the isopeptide bond, it translocates and unfolds both N- and C-terminal substrate segments, while ubiquitins linked to the branchpoint dissociate from UN and move outside the pore, releasing unfolded polyubiquitinated substrate. In vitro reconstitution with purified yeast components, hydrogen–deuterium exchange MS, biochemical translocation assays, mutagenesis Molecular cell High 34951965
2024 Bidirectional substrate shuttling between the 26S proteasome and the Cdc48-Ufd1/Npl4 ATPase complex promotes degradation of well-folded substrates. A minimal reconstituted system requires the 26S proteasome, Cdc48-UN complex, proteasome cofactor Rad23, and Cdc48 cofactors Ubx5 and Shp1: Rad23 and Ubx5 stimulate polyubiquitin binding to the proteasome and Cdc48-UN respectively, allowing competition for substrates; Shp1 stimulates protein unfolding by Cdc48-UN rather than substrate recruitment. In vitro reconstitution with purified yeast components, biochemical degradation assays, yeast genetics confirmation Molecular cell High 38401542
2022 SUMO modification enhances substrate unfolding by the Ufd1/Npl4/Cdc48 complex: interactions between Ufd1 and SUMO accelerate unfolding of substrates modified by SUMO-polyubiquitin hybrid chains compared to polyubiquitin alone. Cryo-EM structures of the complex with a SUMO-polyubiquitin hybrid-chain substrate reveal features of Ufd1/Npl4/Cdc48 interactions with ubiquitin prior to and during unfolding. In vitro unfolding assays with purified yeast proteins, single-particle cryo-EM structural analysis Proceedings of the National Academy of Sciences of the United States of America High 36574706
2009 VCP/p97 is required for autophagosome maturation: loss of VCP activity (by RNAi knockdown or dominant-negative overexpression) results in accumulation of immature autophagosomes under basal conditions; these autophagosomes fail to mature into autolysosomes and degrade LC3. Disease-causing IBMPFD mutants (R155H, A232E) cause the same autophagy defect. VCP is selectively required for autophagic degradation of ubiquitinated substrates but not for starvation-induced autophagy. RNAi knockdown, dominant-negative overexpression, stable dual-tagged LC3 reporter (mCherry-EGFP-LC3), patient-derived myoblasts The Journal of cell biology High 20008565 20104022
2021 VCP/p97 regulates autophagy initiation in two Beclin-1-dependent ways: (1) VCP stabilizes Beclin-1 protein levels by promoting the deubiquitinase activity of ataxin-3 (ATXN3) towards Beclin-1; (2) VCP interacts with and promotes assembly and kinase activity of the Beclin-1-containing PI3K complex I, regulating PI(3)P production. Inhibition of VCP ATPase activity impairs starvation-induced PI(3)P production and limits downstream recruitment of WIPI2, ATG16L, and LC3, decreasing autophagosome formation. Small-molecule VCP ATPase inhibitors, PI(3)P lipid assays, co-immunoprecipitation, deubiquitinase activity assays, WIPI2/ATG16L/LC3 recruitment assays Nature chemical biology High 33510452 33719912
2011 Cdc48/p97, together with cofactors Ufd1-Npl4, Ubx4, and Ubx5, mediates UV-dependent turnover of RNA Pol II largest subunit Rpb1: ubiquitinated Rpb1, proteasomes, and Cdc48 accumulate on chromatin in UV-treated cells; in cdc48 mutants, Ub conjugates accumulate on the proteasome, indicating Cdc48 acts to facilitate processive degradation at sites of stalled transcription rather than solely upstream of the proteasome. Proteasome isolation followed by mass spectrometry, chromatin fractionation, genetic mutant analysis in yeast Molecular cell High 21211725
2005 IBMPFD disease-causing VCP/p97 mutant R155H has normal ATPase activity and hexameric structure, yet impairs ERAD: it increases overall ubiquitin-conjugated proteins and specifically blocks degradation of the ERAD substrate ΔF508-CFTR, similar to ATPase-deficient VCP. IBMPFD mutants also promote formation of aggregates containing VCP, ubiquitin conjugates, and ER-resident proteins. Cell-based ERAD substrate degradation assays, ATPase activity measurement, native gel electrophoresis, immunofluorescence/co-localization in cultured cells Human molecular genetics High 16321991
2011 Cdc48/p97-Ufd1-Npl4 complex removes Aurora B from chromatin during mitotic exit in Xenopus egg extracts; in HeLa cells, Ufd1-Npl4 antagonizes Aurora B on chromosomes from prometaphase onwards. Depletion of Ufd1-Npl4 by siRNA causes increased Aurora B levels and activity on chromosomes, chromosome alignment and anaphase defects, and multi-lobed nuclei; low-dose Aurora B inhibitor partially rescues these defects. siRNA depletion, quantitative immunofluorescence, Aurora B kinase activity assay (CENP-A phosphorylation), genetic epistasis with hesperadin inhibitor in HeLa cells Journal of cell science High 20130676 21486945
2010 In budding yeast, Cdc48-Shp1 complex promotes chromosome bi-orientation by facilitating nuclear localization of the phosphatase Glc7/PP1, which counteracts Ipl1/Aurora B kinase activity at kinetochores. Temperature-sensitive cdc48-3 and Shp1 depletion cause metaphase arrest due to defective bipolar kinetochore attachment and spindle checkpoint activation. Yeast temperature-sensitive mutants, co-immunoprecipitation, nuclear localization imaging, genetic epistasis with ipl1 mutants and kinase inhibitors Journal of cell science High 20483956
2018 Cdc48/VCP promotes chromosome condensation by releasing condensin from chromatin entrapment via ubiquitin-dependent extraction. Condensin traps itself in its own reaction product during chromatin compaction; Cdc48 acts as the central segregase that promotes ubiquitin-dependent cycling of condensin on mitotic chromatin. Yeast genetics, in vivo chromatin binding assays, ubiquitin mutant epistasis, condensin-chromatin dynamics assays Molecular cell Medium 29452641
2013 In yeast, stress granules can be targeted for autophagic degradation (granulophagy) in a process requiring CDC48/VCP. Genetic screen identified CDC48 alleles as affecting stress granule dynamics; in mammalian cells, depletion or pathogenic mutations in VCP reduce stress granule clearance, an effect also seen with autophagy inhibition. Yeast genetic screen (125 genes), fluorescence microscopy of stress granule dynamics, RNAi depletion, patient mutation expression in mammalian cells Cell High 23791177
2019 ULK1 and ULK2 kinases phosphorylate VCP/p97, thereby increasing VCP's ATPase activity and its ability to disassemble stress granules. ULK1/2 localize to stress granules; disrupted ULK1/2 expression in mice causes a vacuolar myopathy similar to VCP disease with TDP-43-positive inclusions. Kinase phosphorylation assays, stress granule disassembly assays, VCP ATPase activity measurement, mouse knockout models, ULK1/2 agonist pharmacology Molecular cell High 30979586
2020 A p.Asp395Gly mutation in VCP is associated with dementia characterized by neurofibrillary tangles. Wild-type VCP exhibits tau disaggregase activity in vitro, which is impaired by the p.Asp395Gly mutation. Intracerebral microinjection of pathologic tau into p.Asp395Gly VCP knock-in mice leads to increased tau aggregates compared to wild-type mice. In vitro tau disaggregation assay with purified VCP, VCP knock-in mouse model with intracerebral tau microinjection, neuropathological analysis Science (New York, N.Y.) High 33004675
2023 In cell culture and neurons, VCP is recruited to ubiquitylated Tau fibrils and efficiently disaggregates them; aggregate clearance depends on functional cooperation of VCP with Hsp70 and the ubiquitin-proteasome machinery. Inhibition of VCP stabilizes large Tau aggregates, whereas VCP-mediated disaggregation generates seeding-active Tau species as a byproduct. Cell culture Tau aggregate clearance assays, VCP inhibitors, VCP depletion, live-cell imaging, seeding activity assays in neurons Nature communications High 36732333
2017 Endogenous VCP negatively regulates Mitofusin, which is required for outer mitochondrial membrane fusion. IBMPFD disease mutants of VCP act as hyperactive alleles with respect to Mitofusin regulation; VCP inhibitors suppress mitochondrial fusion and respiratory defects in IBMPFD patient fibroblasts and in a Drosophila IBMPFD muscle model. Drosophila in vivo IBMPFD muscle model, patient fibroblast assays, VCP inhibitor treatment, mitochondrial morphology/respiration assays eLife Medium 28322724
2016 VCP, together with cofactor P47 and the ER morphology regulator ATL1, regulates tubular ER formation and controls protein synthesis efficiency to influence dendritic spine formation in neurons. Knockdown or disease mutation knockin of VCP reduces dendritic spine density; leucine supplementation (increasing protein synthesis) rescues spine defects caused by VCP deficiency. Knockdown, disease-mutation knockin mice, live imaging of ER morphology, protein synthesis measurement, dendritic spine morphometry in neurons Nature communications Medium 26984393
2009 VCP/p97 is highly modified by phosphorylation and acetylation at numerous sites throughout the protein. Amino acid substitutions at Lys696 and Thr761 (in the D2alpha/VAR domain) profoundly affect VCP ATPase activity, identifying this region as an ATPase regulatory domain. Lys251 and Lys524 (Walker A motifs of D1 and D2 domains) are potential acetylation sites. Mass spectrometry identification of modification sites, site-directed mutagenesis with ATPase activity measurement Genes to cells : devoted to molecular & cellular mechanisms Medium 19335618
2011 The UBX domain protein Ubx4 modulates the Cdc48-Ufd1-Npl4 complex for correct ERAD function. Ubx4 mutants defective in Cdc48 binding lead to defective degradation of ERAD substrates and accumulation of polyubiquitinated proteins bound to Cdc48. Ubx2 and Ubx4 are not found together in one Cdc48 complex, suggesting distinct steps in modulating Cdc48 activity in ERAD. Yeast genetics with ERAD substrate degradation assays, co-immunoprecipitation, polyubiquitin accumulation assays The Journal of biological chemistry Medium 19359248
2018 In budding yeast, defective RNA polymerase III (Pol III) is negatively regulated by a sequential SUMO–ubiquitin–Cdc48 pathway: Pol III is sumoylated, then ubiquitylated, and subsequently targeted by Cdc48/p97 segregase, leading to proteasomal degradation of Pol III subunits and repression of Pol III transcription. Yeast genetics, sumoylation and ubiquitylation assays, Cdc48 mutant analysis, proteasomal degradation assays eLife Medium 30192228
2022 WIPI2 binds VCP/p97 and promotes its recruitment to damaged mitochondria during PINK1-PRKN-mediated mitophagy. WIPI2 depletion blunts VCP recruitment to damaged mitochondria, leading to reduced degradation of outer mitochondrial membrane proteins and impaired mitophagy. Co-immunoprecipitation, RNAi depletion, mitophagy flux assays, OMM protein degradation assays, cell death assays Autophagy Medium 35389758
2021 VCP cofactor UBXN1/SAKS1 translocates to mitochondria upon depolarization in a PRKN-dependent manner and facilitates MFN2 removal from the outer mitochondrial membrane; loss of UBXN1 impairs VCP and PRKN translocation to mitochondria and reduces mitophagic flux. UBXN1 physically interacts with PRKN in a UBX domain-dependent manner. Co-immunoprecipitation, siRNA depletion, mitophagy flux assays, immunofluorescence imaging of mitochondrial translocation, domain mapping Autophagy Medium 33966597
2022 Polo-like kinase 1 (Plk1) phosphorylates VCP/p97 at Thr76, recruiting VCP to the centrosome from prophase to anaphase and regulating centrosome orientation. Dephosphorylation of Thr76 by PTEN is required for VCP and Eg5 enrichment at the mitotic spindle, ensuring proper spindle architecture and chromosome segregation. Cryo-EM structures of phosphomimetic (T76E) and phospho-deficient (T76A) VCP revealed that Thr76 phosphorylation alters inter-domain/inter-subunit interactions and the nucleotide-binding pocket conformation. Kinase assay, phospho-mutant cell biology, siRNA depletion, cryo-EM structural analysis, co-localization imaging, xenograft tumor growth assay Cell death and differentiation High 35430615
2024 VCP/p97 is UFMylated at K109 by the E3 ligase UFL1; this modification promotes BECN1 stabilization through ATXN3-mediated deubiquitination and facilitates assembly of the BECN1-containing PI3K complex, thereby promoting autophagy initiation. UFMylation-defective VCP mutant cannot rescue VCP depletion-induced LC3B accumulation. Several pathogenic VCP mutations are associated with reduced UFMylation. Mass spectrometry identification of UFMylation site, site-directed mutagenesis, co-immunoprecipitation, BECN1 stability assays, LC3B reporter assays Autophagy Medium 38762759
2023 DUSP1 phosphatase interacts with VCP on mitochondria and dephosphorylates VCP at Ser784. LPS-induced endotoxemia promotes VCP Ser784 phosphorylation; DUSP1 overexpression prevents this, preserving mitochondrial quality control. A phosphomimetic VCP S784E mutant abolishes DUSP1's protective effects on mitochondrial dynamics, mitophagy, and cardiomyocyte contractility. Co-immunoprecipitation, phospho-specific antibodies, site-directed mutagenesis (phosphomimetic), DUSP1 transgenic mice and HL-1 cell transfection, mitochondrial function assays Cellular and molecular life sciences : CMLS Medium 37464072
2022 PTP4A2 phosphatase dephosphorylates VCP/p97 at Tyr805; this dephosphorylation enables VCP to associate with its C-terminal cofactors UBXN6/UBXD1 and PLAA, which are components of the ELDR complex responsible for lysophagy (autophagic clearance of damaged lysosomes). Loss of PTP4A2 compromises recovery from acute kidney injury due to impaired lysophagy. Substrate trapping and mass spectrometry, biochemical dephosphorylation assays, co-immunoprecipitation, lysophagy assays, Ptp4a2 knockout mice Autophagy High 36300783
2021 VCP's cofactor FAF1 facilitates VCP-dependent extraction of SUMOylated and ubiquitylated proteins accumulating on chromatin after DNA replication blocks; this VCP(FAF1) activity cooperates with the deubiquitylase USP7 (which maintains a SUMO-high/ubiquitin-low environment at active replication forks). Inactivation of USP7 and FAF1 is synthetically lethal in C. elegans and mammalian cells. Co-immunoprecipitation, chromatin fractionation, C. elegans and mammalian cell genetics, synthetic lethality assays, VCP and USP7 inhibitor synergy Cell reports Medium 34644576
2023 The p97/VCP UFD1-NPLOC4 segregase complex is required for arsenic-induced degradation of PML and PML-RARA. p97/VCP localizes to PML bodies after arsenic treatment; pharmacological p97 inhibition or siRNA depletion of UFD1/NPLOC4 blocks arsenic-induced degradation of PML-RARA, accumulates SUMO- and ubiquitin-modified PML, and alters PML body number, morphology, and size. Proteomic analysis of PML bodies, pharmacological p97 inhibition, siRNA depletion, immunofluorescence, biochemical PML modification analysis The Journal of cell biology Medium 36880596
2024 Inhibited WRN helicase is trapped on chromatin and requires p97/VCP for extraction and proteasomal degradation in microsatellite-instability-high (MSI-H) cancer cells. The PIAS4-RNF4 SUMO-ubiquitin axis is responsible for generating the SUMOylated/ubiquitylated WRN signal recognized by p97/VCP for chromatin extraction. Single-molecule tracking in living cells, pharmacological WRN inhibition, p97 inhibition, PIAS4 and RNF4 genetic epistasis, chromatin fractionation Nature communications Medium 39025847
2023 Ubx5-Cdc48 assists the protease Wss1 in clearing DNA-protein crosslinks (DPCs): Ubx5 accumulates at persistent DPC lesions in the absence of Wss1; abolishing Cdc48 binding by Ubx5 or complete Ubx5 loss suppresses wss1Δ sensitivity to DPC-inducing agents by favoring alternate repair pathways. Ubx5-Cdc48 and Wss1 cooperate in genotoxin-induced degradation of RNA Pol II at DPC lesions. Yeast genetics, inducible site-specific crosslink assay, chromatin immunoprecipitation, genetic epistasis, RNAPII degradation assays The EMBO journal Medium 37144685
1993 VCP forms a stoichiometric complex with clathrin and Hsc70 in mammalian cell lysates within 15 min of synthesis, identifying VCP as a ubiquitous clathrin-binding protein and suggesting a role in modulating protein-protein interactions in membrane transport processes. Biochemical co-purification, co-immunoprecipitation, stoichiometric complex analysis from mammalian cell lysates Nature Medium 8413590
2012 Both Cdc48 and its cofactor Vms1 (but not Ufd1 or Ufd2) are required for degradation of the telomere regulator Cdc13; this degradation involves both autophagy and the proteasome under non-stress conditions. Yeast deletion mutant analysis, Cdc13 stability assays, autophagy and proteasome inhibition genetics The Journal of biological chemistry Medium 22718752
2013 In IBMPFD, all twelve pathogenic p97/VCP missense mutants cause ERAD substrate accumulation. Most IBMPFD mutants show enhanced binding to cofactors p47 and Ufd1-Npl4. However, the P137L mutant uniquely abolishes interactions with Ufd1, Npl4, and p47 while retaining gp78-VIM binding, and shows a distinct solubility profile and subcellular localization compared to other IBMPFD mutants. ERAD substrate degradation assays, in vitro protein-protein binding assays with recombinant proteins, co-immunoprecipitation, subcellular fractionation, immunofluorescence The international journal of biochemistry & cell biology Medium 23333620
2015 An ALS-disease-associated aspartate mutation in the pore-2 loop of the D2 ring of Cdc48/p97 impairs 20S proteasome binding and proteolytic communication but does not affect hexamer stability, ATP hydrolysis rate, or protein unfolding activity, identifying the pore-2 loop as a critical element for direct Cdc48–20S proteasome interaction. In vitro binding assays between purified archaeal/human Cdc48 variants and 20S proteasome, ATPase activity measurement, protein unfolding assays, hexamer stability analysis, site-directed mutagenesis Protein science : a publication of the Protein Society Medium 26134898
2014 Archaeal Cdc48 and 20S proteasome form a stable, enzymatically active coaxial complex stabilized by site-specific cross-linking. The N-terminal domain of Cdc48 packs against the D1 ring in a coplanar fashion in this complex, and the structure demonstrates that coaxial alignment without AAA+ wobbling is sufficient for function. Site-specific chemical cross-linking, single-particle electron microscopy structure determination, in vitro proteolytic activity assay Proceedings of the National Academy of Sciences of the United States of America High 24711419
2019 VCP inactivation in skeletal muscle of adult mice (conditional knockout) causes lysosomal membrane damage, persistent TFEB nuclear localization, and a necrotic myopathy distinct from ATG5 knockout, identifying VCP as a central mediator of both lysosomal clearance and TFEB-regulated lysosomal biogenesis in differentiated muscle. Conditional muscle-specific knockout mice, lysosomal damage markers (LGALS3), TFEB localization by immunofluorescence, comparison with ATG5 knockout mice, chemical lysosomal membrane permeabilization Autophagy High 30654731
2023 Nuclear VCP binds to HDAC1 and facilitates its degradation, thereby promoting transcription of FAO genes including CPT1A, upregulating fatty acid oxidation in colorectal cancer cells. Co-immunoprecipitation, VCP inhibitor and knockdown experiments, chromatin-based transcription assays, HDAC1 stability assays, cancer cell functional assays Proceedings of the National Academy of Sciences of the United States of America Medium 37788309
2025 VCP is a top hit in a proximity-labeling screen for proteins that control tau seed amplification within 5 h of seed exposure. VCP knockdown reduces tau seeding; two VCP inhibitors (ML-240 and NMS-873) have opposing effects on seeding, with effects only observed within 8 h of seed exposure. Screening 30 VCP cofactors identified ATXN3, NSFL1C, UBE4B, NGLY1, OTUB1, and NPLOC4 as suppressors of tau seeding, while FAF2 reduction increases seeding. Split-APEX2 proximity labeling screen, CRISPR/siRNA cofactor screen, tau seeding biosensor assays in HEK293T cells and human neurons, VCP inhibitor pharmacology Molecular neurodegeneration Medium 39773263
2021 Neuronal VCP loss of function (conditional knockout in postnatal forebrain neurons) causes cortical atrophy, neuronal loss, autophagolysosomal dysfunction, and TDP-43 inclusions resembling FTLD-TDP pathology. A single disease-associated VCP-R155C mutation in a VCP null background similarly recapitulates VCP inactivation features, suggesting the R155C MSP mutation is hypomorphic (loss-of-function rather than dominant-negative). Conditional neuronal knockout mice, VCP-R155C knock-in in null background, transcriptomic and proteomic analysis, TDP-43 immunohistochemistry Cell reports Medium 34289347

Source papers

Stage 0 corpus · 100 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2013 Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 622 23791177
2009 Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. The Journal of cell biology 420 20008565
2014 The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis. Journal of cell science 386 25146396
2010 VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 366 20104022
2017 VCP/p97-Mediated Unfolding as a Principle in Protein Homeostasis and Signaling. Molecular cell 339 29153394
2011 Cdc48: a power machine in protein degradation. Trends in biochemical sciences 202 21741246
2011 Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Molecular cell 173 21211725
2005 Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation. Human molecular genetics 166 16321991
2011 The Cdc48 machine in endoplasmic reticulum associated protein degradation. Biochimica et biophysica acta 155 21945179
2019 ULK1 and ULK2 Regulate Stress Granule Disassembly Through Phosphorylation and Activation of VCP/p97. Molecular cell 154 30979586
2010 Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Human molecular genetics 153 20147319
2017 A Mighty "Protein Extractor" of the Cell: Structure and Function of the p97/CDC48 ATPase. Frontiers in molecular biosciences 151 28660197
2011 Recent advances in p97/VCP/Cdc48 cellular functions. Biochimica et biophysica acta 147 21781992
2002 Cdc48-Ufd1-Npl4: stuck in the middle with Ub. Current biology : CB 132 12015140
1993 Valosin-containing protein, VCP, is a ubiquitous clathrin-binding protein. Nature 121 8413590
2021 VCP/p97 regulates Beclin-1-dependent autophagy initiation. Nature chemical biology 114 33510452
2020 Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science (New York, N.Y.) 108 33004675
2017 Toward an understanding of the Cdc48/p97 ATPase. F1000Research 108 28815021
2012 Growing sphere of influence: Cdc48/p97 orchestrates ubiquitin-dependent extraction from chromatin. Trends in cell biology 88 22818974
2013 Cdc48: a swiss army knife of cell biology. Journal of amino acids 82 24167726
2008 Mechanisms of Cdc48/VCP-mediated cell death: from yeast apoptosis to human disease. Biochimica et biophysica acta 79 18284922
2017 Valosin-containing protein (VCP/p97) inhibitors relieve Mitofusin-dependent mitochondrial defects due to VCP disease mutants. eLife 78 28322724
2016 Ring of Change: CDC48/p97 Drives Protein Dynamics at Chromatin. Frontiers in genetics 77 27200082
2013 Role of p97/VCP (Cdc48) in genome stability. Frontiers in genetics 76 23641252
2012 Expanding into new markets--VCP/p97 in endocytosis and autophagy. Journal of structural biology 74 22450227
2023 The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system. Nature communications 66 36732333
2016 VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation. Nature communications 66 26984393
2021 Translocation of polyubiquitinated protein substrates by the hexameric Cdc48 ATPase. Molecular cell 65 34951965
2015 Origin and Functional Evolution of the Cdc48/p97/VCP AAA+ Protein Unfolding and Remodeling Machine. Journal of molecular biology 65 26608813
2023 Inhibitors of the ATPase p97/VCP: From basic research to clinical applications. Cell chemical biology 64 36640759
2019 VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle. Autophagy 58 30654731
2008 Roles of VCP in human neurodegenerative disorders. Biochemical Society transactions 53 18208395
2014 Architecture and assembly of the archaeal Cdc48*20S proteasome. Proceedings of the National Academy of Sciences of the United States of America 52 24711419
2011 Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model. PLoS genetics 51 21304887
2017 The role of ubiquitin-dependent segregase p97 (VCP or Cdc48) in chromatin dynamics after DNA double strand breaks. Philosophical transactions of the Royal Society of London. Series B, Biological sciences 50 28847819
2011 Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in HeLa cells. Journal of cell science 49 21486945
2016 Strategic role of the ubiquitin-dependent segregase p97 (VCP or Cdc48) in DNA replication. Chromosoma 47 27086594
2022 Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis. Genes 44 35741724
2013 Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP. Biochimica et biophysica acta 44 23583830
2009 p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation. Genes to cells : devoted to molecular & cellular mechanisms 44 19335618
2023 Valosin containing protein (VCP): initiator, modifier, and potential drug target for neurodegenerative diseases. Molecular neurodegeneration 42 37545006
2007 APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD). Genetics in medicine : official journal of the American College of Medical Genetics 42 17224685
2022 VCP suppresses proteopathic seeding in neurons. Molecular neurodegeneration 41 35414105
2022 WIPI2 positively regulates mitophagy by promoting mitochondrial recruitment of VCP. Autophagy 40 35389758
2022 Valosin Containing Protein (VCP): A Multistep Regulator of Autophagy. International journal of molecular sciences 37 35216053
2022 The functional importance of VCP to maintaining cellular protein homeostasis. Biochemical Society transactions 37 36196920
2021 Neuronal VCP loss of function recapitulates FTLD-TDP pathology. Cell reports 35 34289347
2018 Cdc48/VCP Promotes Chromosome Morphogenesis by Releasing Condensin from Self-Entrapment in Chromatin. Molecular cell 35 29452641
2010 The AAA-ATPase Cdc48 and cofactor Shp1 promote chromosome bi-orientation by balancing Aurora B activity. Journal of cell science 35 20483956
2009 Ubx4 modulates cdc48 activity and influences degradation of misfolded proteins of the endoplasmic reticulum. The Journal of biological chemistry 35 19359248
2013 A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization. The international journal of biochemistry & cell biology 33 23333620
2021 VCP/p97 cofactor UBXN1/SAKS1 regulates mitophagy by modulating MFN2 removal from mitochondria. Autophagy 32 33966597
2023 Targeting of client proteins to the VCP/p97/Cdc48 unfolding machine. Frontiers in molecular biosciences 31 36825201
2016 IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation. PloS one 29 27768726
2013 Roles of Cdc48 in regulated protein degradation in yeast. Sub-cellular biochemistry 29 23479442
2008 Role(s) of Cdc48/p97 in mitosis. Biochemical Society transactions 29 18208399
2023 DUSP1 interacts with and dephosphorylates VCP to improve mitochondrial quality control against endotoxemia-induced myocardial dysfunction. Cellular and molecular life sciences : CMLS 28 37464072
2018 Toward the understanding of the role of CDC48, a major component of the protein quality control, in plant immunity. Plant science : an international journal of experimental plant biology 28 30709491
2017 VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy. Current molecular medicine 28 29521227
2024 VCP/p97 UFMylation stabilizes BECN1 and facilitates the initiation of autophagy. Autophagy 27 38762759
2018 Three VCP Mutations in Patients with Frontotemporal Dementia. Journal of Alzheimer's disease : JAD 26 30103325
2015 Cdc48-independent proteasomal degradation coincides with a reduced need for ubiquitylation. Scientific reports 26 25556859
2020 Cdc48/VCP and Endocytosis Regulate TDP-43 and FUS Toxicity and Turnover. Molecular and cellular biology 25 31767634
2023 Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. Proceedings of the National Academy of Sciences of the United States of America 24 37788309
2021 VPS13D interacts with VCP/p97 and negatively regulates endoplasmic reticulum-mitochondria interactions. Molecular biology of the cell 24 34133214
2018 Defective RNA polymerase III is negatively regulated by the SUMO-Ubiquitin-Cdc48 pathway. eLife 24 30192228
2012 A novel VCP mutation as the cause of atypical IBMPFD in a Chinese family. Bone 24 23000505
2023 TNF-α-Induced KAT2A Impedes BMMSC Quiescence by Mediating Succinylation of the Mitophagy-Related Protein VCP. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 23 38145956
2016 Structure and functions of the chaperone-like p97/CDC48 in plants. Biochimica et biophysica acta. General subjects 22 27717811
2024 Bidirectional substrate shuttling between the 26S proteasome and the Cdc48 ATPase promotes protein degradation. Molecular cell 21 38401542
2021 CRISPR/Cas9-engineered Drosophila knock-in models to study VCP diseases. Disease models & mechanisms 21 34160014
2021 How Viruses Use the VCP/p97 ATPase Molecular Machine. Viruses 21 34578461
2020 VCP expression decrease as a biomarker of preclinical and early clinical stages of Parkinson's disease. Scientific reports 21 31964996
2012 Protective role of cell division cycle 48 (CDC48) protein against neurodegeneration via ubiquitin-proteasome system dysfunction during zebrafish development. The Journal of biological chemistry 21 22549779
2022 SUMO enhances unfolding of SUMO-polyubiquitin-modified substrates by the Ufd1/Npl4/Cdc48 complex. Proceedings of the National Academy of Sciences of the United States of America 20 36574706
2020 Mitochondrial Surveillance by Cdc48/p97: MAD vs. Membrane Fusion. International journal of molecular sciences 20 32961852
2024 Valosin-Containing Protein (VCP): A Review of Its Diverse Molecular Functions and Clinical Phenotypes. International journal of molecular sciences 19 38891822
2023 Keratinocyte FABP5-VCP complex mediates recruitment of neutrophils in psoriasis. Cell reports 19 37967009
2015 An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication. Protein science : a publication of the Protein Society 19 26134898
2023 Targeting VCP potentiates immune checkpoint therapy for colorectal cancer. Cell reports 18 37865914
2024 Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis. Cell death & disease 17 38218922
2023 The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. The Journal of cell biology 17 36880596
2021 Versatile control of the CDC48 segregase by the plant UBX-containing (PUX) proteins. Computational and structural biotechnology journal 17 34141135
2021 USP7 and VCPFAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork. Cell reports 17 34644576
2024 VCP activator reverses nuclear proteostasis defects and enhances TDP-43 aggregate clearance in multisystem proteinopathy models. The Journal of clinical investigation 16 38787785
2024 WRN inhibition leads to its chromatin-associated degradation via the PIAS4-RNF4-p97/VCP axis. Nature communications 16 39025847
2023 XAF1 promotes colorectal cancer metastasis via VCP-RNF114-JUP axis. The Journal of cell biology 16 38095639
2022 P97/VCP ATPase inhibitors can rescue p97 mutation-linked motor neuron degeneration. Brain communications 16 35865348
2018 The involvement of endoplasmic reticulum formation and protein synthesis efficiency in VCP- and ATL1-related neurological disorders. Journal of biomedical science 16 29310658
2021 The chaperone-like protein Cdc48 regulates ubiquitin-proteasome system in plants. Plant, cell & environment 15 33908641
2019 The chaperone-like protein CDC48 regulates ascorbate peroxidase in tobacco. Journal of experimental botany 15 30821322
2025 VCP regulates early tau seed amplification via specific cofactors. Molecular neurodegeneration 14 39773263
2023 Ubx5-Cdc48 assists the protease Wss1 at DNA-protein crosslink sites in yeast. The EMBO journal 14 37144685
2022 The phosphorylation and dephosphorylation switch of VCP/p97 regulates the architecture of centrosome and spindle. Cell death and differentiation 14 35430615
2021 VCP/p97 modulates PtdIns3P production and autophagy initiation. Autophagy 14 33719912
2020 Kushenol E inhibits autophagy and impairs lysosomal positioning via VCP/p97 inhibition. Biochemical pharmacology 14 32081789
2018 Cdc48-like protein of actinobacteria (Cpa) is a novel proteasome interactor in mycobacteria and related organisms. eLife 14 29809155
2010 A role for Cdc48/p97 and Aurora B in controlling chromatin condensation during exit from mitosis. Biochemistry and cell biology = Biochimie et biologie cellulaire 14 20130676
2022 PTP4A2 promotes lysophagy by dephosphorylation of VCP/p97 at Tyr805. Autophagy 13 36300783
2012 The Cdc48 protein and its cofactor Vms1 are involved in Cdc13 protein degradation. The Journal of biological chemistry 13 22718752

Missed literature

Know a paper Affinage missed for VCP? Flag it for the maintainers and the community.

No submissions yet.